SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VERISANTE TECHNOLOGY

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: andre dallaire2/16/2012 3:20:35 PM
   of 254
 
Verisante Technology added to TSX-V's top 50
Ticker Symbol: C:VRS Verisante Technology added to TSX-V's top 50 Verisante Technology Inc (C:VRS)
Shares Issued 64,594,732
Last Close 2/15/2012 $0.68
Thursday February 16 2012 - News Release

Mr. Thomas Braun reports

VERISANTE TECHNOLOGY INC. NAMED TOP TECHNOLOGY AND LIFE SCIENCES COMPANY ON THE TSX VENTURE TOP 50 2012 RANKING

Verisante Technology Inc. has learned of its naming as this year's top-ranking technology and life sciences company on the TSX Venture 50.

The TSX Venture Exchange's annual list of its top 50 emerging publicly traded companies is a ranking of the strongest performers from five industry sectors. Verisante ranked number one on the list of top 10 leading Technology and Life Sciences companies for the year. Companies are selected based on four equally weighted criteria -- return on investment, trading activity, market capitalization growth, and analyst coverage. The results were obtained from data to December 31, 2011.

As the top ranking Technology and Life Sciences Company, Verisante has been invited to attend the TSX Venture 50 Spotlight event on April 3, 2012 in Toronto, with an opportunity to present to an audience comprised of portfolio managers, investment bankers, research analysts and investment advisors.

"The number one ranking by the TSX Venture Exchange underscores the breakthrough year the Company has had," said Thomas Braun, President and CEO. "The approval of Verisante Aura for use in the key Canadian, European and Australian markets and the industry recognition our technologies have recently received demonstrate that we are moving forward on our commitment to helping healthcare providers save lives through the detection of some of the most common forms of cancer."

Verisante Aura has also recently been awarded Popular Science Magazine's "Best of What's New Award" for 2011, and Verisante Core was named one of the top 10 cancer breakthroughs of 2011 by the Canadian Cancer Society. In addition, the Company was named a finalist for the 2011 Regional Awards for New Technology by the Canadian Manufacturers & Exporters and the National Research Council of Canada.

We seek Safe Harbor.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext